Precision BioSciences IncPrecision BioSciences Inc - ESG Rating & Company Profile powered by AI

Industry Group:Pharmaceuticals

The Disclosure score covers 17 United Nations SDGs including: 'Zero Hunger', 'Decent Work & Economic Growth' and 'Partnerships for the Goals'. Alternative companies in the rating industry group for Precision BioSciences Inc are shownin the table. If you work at Precision BioSciences Inc and you wish to use your Sustainability aseessment, please get in touch.

Precision BioSciences Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.7; made up of an environmental score of 6.0, social score of 3.2 and governance score of 4.8.

SDG Transparency Score for Precision BioSciences Inc 
Low
0 - 3

4.7

Medium Impact
4 - 6
High
7 - 10
Last Score Update: 2024-05-01
What drives the score for Precision BioSciences Inc 
6.0

Environmental

3.2

Social

4.8

Governance

Detailed ESG Breakdown
SEVVA Platform offers unique drill down to the underlying sources powering the ratings. Break down your ESG analysis by 17 UN SDGs and 8 additional governance factors.

Peer Group Comparison

RankCompanySDG Transparency Score Performance
1Caladrius Biosciences Inc
8.0
High
1Can Fite Biopharma Ltd
8.0
High
816Pliant Therapeutics Inc
4.8
High
816Voyager Therapeutics Inc
4.8
High
837Precision BioSciences Inc
4.7
High
837Bio Rad Laboratories Inc
4.7
High
837Katakura Industries Co Ltd
4.7
High
.........
1970Zyden Gentec Ltd
0.0
Low
1970iNtRON Biotechnology Inc
0.0
Low
.........
View the full peer group of 3273 companies on the SEVVA platformSign up for free
Peer Companies Benchmark
SEVVA Platform benchmarks each company against a peer group. View the full score distribution for peers by logging into SEVVA

Frequently Asked Questions

Does Precision BioSciences Inc have an accelerator or VC vehicle to help deliver innovation?

LockedSign up for free to unlock

Does Precision BioSciences Inc disclose current and historical energy intensity?

LockedSign up for free to unlock

Does Precision BioSciences Inc report the average age of the workforce?

LockedSign up for free to unlock

Does Precision BioSciences Inc reference operational or capital allocation in relation to climate change?

LockedSign up for free to unlock

Does Precision BioSciences Inc disclose its ethnicity pay gap?

LockedSign up for free to unlock

Does Precision BioSciences Inc disclose cybersecurity risks?

LockedSign up for free to unlock

Does Precision BioSciences Inc offer flexible work?

LockedSign up for free to unlock

Does Precision BioSciences Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?

LockedSign up for free to unlock

Does Precision BioSciences Inc disclose the number of employees in R&D functions?

LockedSign up for free to unlock

Does Precision BioSciences Inc conduct supply chain audits?

LockedSign up for free to unlock

Does Precision BioSciences Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')

LockedSign up for free to unlock

Does Precision BioSciences Inc conduct 360 degree staff reviews?

LockedSign up for free to unlock

Does Precision BioSciences Inc disclose the individual responsible for D&I?

LockedSign up for free to unlock

Does Precision BioSciences Inc disclose current and historical air emissions?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')

LockedSign up for free to unlock

Is executive remuneration linked to climate performance?

LockedSign up for free to unlock

Does the Board describe its role in the oversight of climate-related risks and opportunities?

LockedSign up for free to unlock

Does Precision BioSciences Inc disclose current and / or historical scope 2 emissions?

LockedSign up for free to unlock

Does Precision BioSciences Inc disclose water use targets?

LockedSign up for free to unlock

Does Precision BioSciences Inc have careers partnerships with academic institutions?

LockedSign up for free to unlock

Did Precision BioSciences Inc have a product recall in the last two years?

LockedSign up for free to unlock

Does Precision BioSciences Inc disclose incidents of discrimination?

LockedSign up for free to unlock

Does Precision BioSciences Inc allow for Work Councils/Collective Agreements to be formed?

LockedSign up for free to unlock

Has Precision BioSciences Inc issued a profit warning in the past 24 months?

LockedSign up for free to unlock

Does Precision BioSciences Inc disclose parental leave metrics?

LockedSign up for free to unlock

Does Precision BioSciences Inc disclose climate scenario or pathway analysis?

LockedSign up for free to unlock

Does Precision BioSciences Inc disclose current and / or historical scope 1 emissions?

LockedSign up for free to unlock

Are Operating Expesnses linked to emissions reduction?

LockedSign up for free to unlock

Does Precision BioSciences Inc disclose the pay ratio of women to men?

LockedSign up for free to unlock

Does Precision BioSciences Inc support suppliers with sustainability related research and development?

LockedSign up for free to unlock

Does Precision BioSciences Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?

LockedSign up for free to unlock

Does Precision BioSciences Inc reflect climate-related risks in its financial statements?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')

LockedSign up for free to unlock

Is Precision BioSciences Inc involved in embryonic stem cell research?

LockedSign up for free to unlock

Does Precision BioSciences Inc disclose GHG and Air Emissions intensity?

LockedSign up for free to unlock

Does Precision BioSciences Inc disclose its waste policy?

LockedSign up for free to unlock

Does Precision BioSciences Inc report according to TCFD requirements?

LockedSign up for free to unlock

Does Precision BioSciences Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?

LockedSign up for free to unlock

Does Precision BioSciences Inc disclose energy use targets?

LockedSign up for free to unlock

Does Precision BioSciences Inc disclose its Renewable Energy targets?

Only SubscribersSubscription required

Are emissions metrics verified by STBi?

Only SubscribersSubscription required

Does Precision BioSciences Inc have a policy relating to cyber security?

LockedSign up for free to unlock

Have a different question?

Potential Risks for Precision BioSciences Inc
These potential risks are based on the size, segment and geographies of the company.

Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific type of immune cell is genetically engineered to recognize and kill cancer cells; PBCAR0191, which is in Phase 1/2a clinical trial in adult patients with R/R NHL or R/R B-cell precursor acute lymphoblastic leukemia, or B-ALL; PBCAR19B, an anti-CD19 CAR T candidate built on the stealth cell platform utilizing a single-step gene edit to minimize the risk of chromosome abnormalities; and PBCAR269A, an investigational allogeneic CAR T immunotherapy targeting BCMA for the treatment of R/R multiple myeloma. The company has development and commercial license agreement with Les Laboratoires Servier to develop allogeneic chimeric antigen receptor T cell therapies for antigen targets, hematological cancer targets beyond CD19, and solid tumor targets; Tiziana Life Sciences to evaluate foralumab, a fully human anti-CD3 monoclonal antibody as a lymphodepleting agent for the potential treatment of cancers; and iECURE, Inc. to develop ARCUS-based gene editing therapies. Precision BioSciences, Inc. was incorporated in 2006 and is headquartered in Durham, North Carolina.

Sorry!

Failed to process!